Altathera Drug Patent Portfolio
Altathera owns 1 orange book drug protected by 6 US patents Given below is the list of Altathera's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11583216 | Method of administering sotalol IV/switch | 21 Aug, 2039 | Active |
| US10799138 | Method of administering sotalol IV/switch | 05 Apr, 2039 | Active |
| US10512620 | Method of initiating and escalating sotalol hydrochloride dosing | 14 Aug, 2038 | Active |
| US11696902 | Method of initiating and escalating sotalol hydrochloride dosing | 14 Aug, 2038 | Active |
| US12390431 | 14 Aug, 2038 | Active | |
| US12403109 | 14 Aug, 2028 | Active |
Latest Legal Activities on Altathera's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Altathera.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 15 Apr, 2024 | US10799138 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 26 Dec, 2023 | US11850222 |
|
Email Notification
Critical
| 26 Dec, 2023 | US11850222 |
| Recordation of Patent eGrant | 26 Dec, 2023 | US11850222 |
| Patent eGrant Notification | 26 Dec, 2023 | US11850222 |
| Mail Patent eGrant Notification | 26 Dec, 2023 | US11850222 |
|
Recordation of Patent Grant Mailed
Critical
| 26 Dec, 2023 | US11850222 |
|
Email Notification
Critical
| 07 Dec, 2023 | US11850222 |
|
Issue Notification Mailed
Critical
| 06 Dec, 2023 | US11850222 |
| Dispatch to FDC | 13 Nov, 2023 | US11850222 |
|
Application Is Considered Ready for Issue
Critical
| 13 Nov, 2023 | US11850222 |
|
Issue Fee Payment Verified
Critical
| 06 Nov, 2023 | US11850222 |
|
Issue Fee Payment Received
Critical
| 06 Nov, 2023 | US11850222 |
| Printer Rush- No mailing | 29 Sep, 2023 | US11850222 |
|
Case Docketed to Examiner in GAU
Critical
| 21 Sep, 2023 | US11850222 |
Altathera's Family Patents
Altathera Drug List
Given below is the complete list of Altathera's drugs and the patents protecting them.
1. Sotalol Hydrochloride
Sotalol Hydrochloride is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11583216 | Method of administering sotalol IV/switch |
21 Aug, 2039
(13 years from now)
| Active |
| US10799138 | Method of administering sotalol IV/switch |
05 Apr, 2039
(13 years from now)
| Active |
| US10512620 | Method of initiating and escalating sotalol hydrochloride dosing |
14 Aug, 2038
(12 years from now)
| Active |
| US11696902 | Method of initiating and escalating sotalol hydrochloride dosing |
14 Aug, 2038
(12 years from now)
| Active |
| US12390431 |
14 Aug, 2038
(12 years from now)
| Active | |
| US12403109 |
14 Aug, 2028
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sotalol Hydrochloride's drug page